Business Description
DermTech Inc
NAICS : 621512
SIC : 8099
ISIN : US24984K1051
Description
DermTech Inc is an emerging growth molecular diagnostic company. The company is engaged in marketing and developing novel non-invasive genomic tests to aid in the diagnosis of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. While the company generates revenue through laboratory services.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.73 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.34 | |||||
| Debt-to-EBITDA | -0.62 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Beneish M-Score | -3.91 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.6 | |||||
| 3-Year EBITDA Growth Rate | -13.5 | |||||
| 3-Year EPS without NRI Growth Rate | -14.1 | |||||
| 3-Year FCF Growth Rate | -9.9 | |||||
| 3-Year Book Growth Rate | -17.8 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.53 | |||||
| Quick Ratio | 3.46 | |||||
| Cash Ratio | 3.11 | |||||
| Days Inventory | 30.34 | |||||
| Days Sales Outstanding | 75.69 | |||||
| Days Payable | 46.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 8.51 | |||||
| Operating Margin % | -588.62 | |||||
| Net Margin % | -572.19 | |||||
| FCF Margin % | -461.26 | |||||
| ROE % | -122.59 | |||||
| ROA % | -64.3 | |||||
| ROIC % | -129.62 | |||||
| ROC (Joel Greenblatt) % | -158.18 | |||||
| ROCE % | -73.62 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.16 | |||||
| EV-to-EBITDA | -0.17 | |||||
| EV-to-Revenue | 0.94 | |||||
| EV-to-Forward-Revenue | 0.14 | |||||
| EV-to-FCF | -0.2 | |||||
| Earnings Yield (Greenblatt) % | -625 | |||||
| FCF Yield % | -1685300 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DermTech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 268.316 | ||
| EPS (TTM) (MXN) | -46.287 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (MXN) | 0 | ||
| 20-Day SMA (MXN) | 55.65 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (MXN) | 55.65 - 55.65 | ||
| Shares Outstanding (Mil) | 34.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DermTech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DermTech Inc Stock Events
| Event | Date | Price(MXN) | ||
|---|---|---|---|---|
| No Event Data | ||||
DermTech Inc Frequently Asked Questions
What is DermTech Inc(MEX:DMTK)'s stock price today?
The current price of MEX:DMTK is MXN55.65. The 52 week high of MEX:DMTK is MXN55.65 and 52 week low is MXN55.65.
When is next earnings date of DermTech Inc(MEX:DMTK)?
The next earnings date of DermTech Inc(MEX:DMTK) is 2024-12-31 Est..
Does DermTech Inc(MEX:DMTK) pay dividends? If so, how much?
DermTech Inc(MEX:DMTK) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers